Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
01/18/2012
Trade Name:
Viread
Generic or Proper Name (*):
tenofovir disoproxil fumarate
Indications Studied:
Treatment of HIV infection in combination with other antiretroviral agents
Therapeutic Category:
Antiviral
Ages Studied:
2-<12 years
Study #:
1
Study Type:
Efficacy/Safety
Study Design:
Open Label/Active Control
No Patients:
97
No Centers:
9
No Countries:
3
BPCA(B), PREA(P):
B,P
White:
9
American Indian/Alaska Native:
2
Countries:
US (6), Panama (1), United Kingdom (2)
-
-